Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Emerging Roles of Long Non-Coding Rna Ftx in Human Disorders Publisher Pubmed



Sheykhisabzehpoush M1 ; Ghasemian M2 ; Khojasteh Pour F3 ; Mighani M4 ; Moghanibashi M5 ; Mohammad Jafari R6 ; Zabel M7, 8 ; Dziegiel P8 ; Farzaneh M6 ; Kempisty B9, 10, 11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Laboratory, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  3. 3. Department of Obstetrics and Gynecology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  4. 4. School of Medicine, Golestan University of Medical Sciences, Golestan, Iran
  5. 5. Department of Genetics, Faculty of Medicine, Kazerun Branch, Islamic Azad University, Kazerun, Iran
  6. 6. Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  7. 7. Division of Anatomy and Histology, University of Zielona Gora, Zielona Gora, 65-046, Poland
  8. 8. Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, Wroclaw, 50-368, Poland
  9. 9. Department of Human Morphology and Embryology, Division of Anatomy, Wroclaw Medical, University, Wroclaw, Poland
  10. 10. Institute of Veterinary Medicine, Department of Veterinary Surgery, Nicolaus Copernicus University, Torun, Poland
  11. 11. North Carolina State University College of Agriculture and Life Sciences, Raleigh, 27695, NC, United States

Source: Clinical and Translational Oncology Published:2023


Abstract

Long non-coding RNAs (lncRNAs) are involved the progression of cancerous and non-cancerous disorders via different mechanism. FTX (five prime to xist) is an evolutionarily conserved lncRNA that is located upstream of XIST and regulates its expression. FTX participates in progression of various malignancy including gastric cancer, glioma, ovarian cancer, pancreatic cancer, and retinoblastoma. Also, FTX can be involved in the pathogenesis of non-cancerous disorders such as endometriosis and stroke. FTX acts as competitive endogenous RNA (ceRNA) and via sponging various miRNAs, including miR-186, miR-200a-3p, miR-215-3p, and miR-153-3p to regulate the expression of their downstream target. FTX by targeting various signaling pathways including Wnt/β-catenin, PI3K/Akt, SOX4, PDK1/PKB/GSK-3β, TGF-β1, FOXA2, and PPARγ regulate molecular mechanism involved in various disorders. Dysregulation of FTX is associated with an increased risk of various disorders. Therefore, FTX and its downstream targets may be suitable biomarkers for the diagnosis and treatment of human malignancies. In this review, we summarized the emerging roles of FTX in human cancerous and non-cancerous cells. © 2023, The Author(s), under exclusive licence to Federacion de Sociedades Espanolas de Oncologia (FESEO).